BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35023320)

  • 1. A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer.
    Hao Q; Huang Z; Li Q; Liu D; Wang P; Wang K; Li J; Cao W; Deng W; Wu K; Su R; Liu Z; Vadgama J; Wu Y
    Adv Sci (Weinh); 2022 Feb; 9(6):e2102303. PubMed ID: 35023320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.
    Benjamin D; Robay D; Hindupur SK; Pohlmann J; Colombi M; El-Shemerly MY; Maira SM; Moroni C; Lane HA; Hall MN
    Cell Rep; 2018 Dec; 25(11):3047-3058.e4. PubMed ID: 30540938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: Role of monocarboxylate transporter.
    Singh SV; Chaube B; Mayengbam SS; Singh A; Malvi P; Mohammad N; Deb A; Bhat MK
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166011. PubMed ID: 33212188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of PP2Cδ By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression
    Wu K; Yu X; Huang Z; Zhu D; Yi X; Wu YL; Hao Q; Kemp KT; Elshimali Y; Iyer R; Nguyen KT; Zheng S; Chen G; Chen QH; Wang G; Vadgama JV; Wu Y
    Antioxid Redox Signal; 2019 Jun; 30(17):1983-1998. PubMed ID: 29808718
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
    Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
    J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells.
    Nadai T; Narumi K; Furugen A; Saito Y; Iseki K; Kobayashi M
    Biol Pharm Bull; 2021; 44(9):1247-1253. PubMed ID: 34471053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis.
    Yuan C; Zhang J; Lou J; Wang S; Jiang Y; Wu F; Wang S
    Bioengineered; 2021 Dec; 12(1):3850-3863. PubMed ID: 34269158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 5-{2-[5-Chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl}-4-methoxypyridine-2-carboxylic Acid, a Highly Selective in Vivo Useable Chemical Probe to Dissect MCT4 Biology.
    Heinrich T; Sala-Hojman A; Ferretti R; Petersson C; Minguzzi S; Gondela A; Ramaswamy S; Bartosik A; Czauderna F; Crowley L; Wahra P; Schilke H; Böpple P; Dudek Ł; Leś M; Niedziejko P; Olech K; Pawlik H; Włoszczak Ł; Zuchowicz K; Suarez Alvarez JR; Martyka J; Sitek E; Mikulski M; Szczęśniak J; Jäckel S; Krier M; Król M; Wegener A; Gałęzowski M; Nowak M; Becker F; Herhaus C
    J Med Chem; 2021 Aug; 64(16):11904-11933. PubMed ID: 34382802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.
    Queirós O; Preto A; Pacheco A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Ko YH; Pedersen PL; Baltazar F; Casal M
    J Bioenerg Biomembr; 2012 Feb; 44(1):141-53. PubMed ID: 22350013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.
    Todenhöfer T; Seiler R; Stewart C; Moskalev I; Gao J; Ladhar S; Kamjabi A; Al Nakouzi N; Hayashi T; Choi S; Wang Y; Frees S; Daugaard M; Oo HZ; Fisel P; Schwab M; Schaeffeler E; Douglas J; Hennenlotter J; Bedke J; Gibb EA; Fazli L; Stenzl A; Black PC
    Mol Cancer Ther; 2018 Dec; 17(12):2746-2755. PubMed ID: 30262589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NF-κB/miR-425-5p/MCT4 axis: A novel insight into diabetes-induced endothelial dysfunction.
    Luo E; Wang D; Yan G; Qiao Y; Zhu B; Liu B; Hou J; Tang C
    Mol Cell Endocrinol; 2020 Jan; 500():110641. PubMed ID: 31711985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to Pb and Cd alters MCT4/CD147 expression and MCT4/CD147-dependent lactate transport in mice Sertoli cells cultured in vitro.
    Yu J; Sun J; Fan Y; Su J; Xie J; Wu Y; Liu X; Wang C
    Toxicol In Vitro; 2019 Apr; 56():30-40. PubMed ID: 30615929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4).
    Papakonstantinou E; Vlachakis D; Thireou T; Vlachoyiannopoulos PG; Eliopoulos E
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.
    Vander Linden C; Corbet C; Bastien E; Martherus R; Guilbaud C; Petit L; Wauthier L; Loriot A; De Smet C; Feron O
    Cell Rep; 2021 Jun; 35(9):109202. PubMed ID: 34077729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
    Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
    Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and male reproduction: effects on Sertoli cell metabolism.
    Alves MG; Martins AD; Vaz CV; Correia S; Moreira PI; Oliveira PF; Socorro S
    Br J Pharmacol; 2014 Feb; 171(4):1033-42. PubMed ID: 24261663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acid test for metformin
    Benjamin D
    J Pathol; 2023 Aug; 260(4):365-367. PubMed ID: 37325933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments.
    Contreras-Baeza Y; Sandoval PY; Alarcón R; Galaz A; Cortés-Molina F; Alegría K; Baeza-Lehnert F; Arce-Molina R; Guequén A; Flores CA; San Martín A; Barros LF
    J Biol Chem; 2019 Dec; 294(52):20135-20147. PubMed ID: 31719150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.